Lisata Therapeutics's market cap is currently $21.40M. The company's EPS TTM is $-2.509; its P/E ratio is ―; Lisata Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.76. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 121.37M	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -189.00K	$ 63.77M	$ -55.00K	$ -63.00K	$ -65.00K
Operating Income	$ -25.71M	$ -57.60M	$ -29.05M	$ -19.14M	$ -20.09M
EBITDA	$ -25.52M	$ -115.20M	$ -29.00M	$ -19.08M	$ -20.03M
Net Income	$ -20.84M	$ -54.23M	$ -27.47M	$ -8.14M	$ -20.10M
Balance Sheet
Cash & Short-Term Investments	$ 50.53M	$ 69.23M	$ 94.97M	$ 34.57M	$ 25.16M
Total Assets	$ 54.69M	$ 73.03M	$ 97.01M	$ 36.00M	$ 27.15M
Total Debt	$ 305.00K	$ 485.00K	$ 714.00K	$ 624.00K	$ 354.00K
Net Debt	$ -22.29M	$ -31.67M	$ -23.93M	$ -15.89M	$ -13.68M
Total Liabilities	$ 6.80M	$ 6.71M	$ 5.01M	$ 3.76M	$ 6.60M
Stockholders' Equity	$ 48.15M	$ 66.58M	$ 92.25M	$ 32.50M	$ 20.82M
Cash Flow
Free Cash Flow	$ -20.03M	$ -21.45M	$ -22.30M	$ -8.84M	$ -18.88M
Operating Cash Flow	$ -20.03M	$ -21.17M	$ -22.25M	$ -8.82M	$ -18.88M
Investing Cash Flow	$ 10.10M	$ 28.91M	$ -54.90M	$ -7.28M	$ 21.43M
Financing Cash Flow	$ 385.00K	$ -224.00K	$ 85.28M	$ 18.58M	$ 1.18M

Currency in USD

Lisata Therapeutics Earnings and Revenue History

Income Statement >

Lisata Therapeutics Debt to Assets

Balance Sheet >

Lisata Therapeutics Cash Flow

Cash Flow >

Lisata Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing